SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001104659-21-105119
Filing Date
2021-08-13
Accepted
2021-08-13 16:16:38
Documents
4
Group Members
AARON GLENN LOUIS FLETCHERBIOS ADVISORS GP, LLCBIOS CAPITAL MANAGEMENT, LPBIOS EQUITY PARTNERS II, LPBIOS EQUITY PARTNERS III, LPBIOS EQUITY PARTNERS, LPBIOS FUND II NT, LPBIOS FUND II QP, LPBIOS FUND III NT, LPBIOS FUND III QP, LPBIOS FUND III, LPBIOS IN

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D tm2124717d1_sc13d.htm SC 13D 495827
2 EXHIBIT 99.A tm2124717d1_exa.htm EX-99.A 102306
3 EXHIBIT 99.B tm2124717d1_exb.htm EX-99.B 46951
4 EXHIBIT 99.E tm2124717d1_exe.htm EX-99.E 18804
  Complete submission text file 0001104659-21-105119.txt   666101
Mailing Address 1401 FOCH STREET SUITE 140 FORT WORTH TX 76107
Business Address 1401 FOCH STREET SUITE 140 FORT WORTH TX 76107 817-984-5964
BIOS Fund II, LP (Filed by) CIK: 0001714576 (see all company filings)

IRS No.: 822436048 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 79 MADISON AVENUE, 2ND FLOOR NEW YORK NY 10016
Business Address 79 MADISON AVENUE, 2ND FLOOR NEW YORK NY 10016 (646) 600-6438
IN8BIO, INC. (Subject) CIK: 0001740279 (see all company filings)

IRS No.: 825462585 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-92777 | Film No.: 211172371
SIC: 2836 Biological Products, (No Diagnostic Substances)